Empresa MedX Health Corp. Toronto S.E.
Acciones
MDX
CA5850901037
Equipo médico y tecnología avanzada
Resumen de negocios
Ventas por actividad
CAD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Phototherapeutic Lasers
64,4
%
| 0 | 48,7 % | 0 | 64,4 % | +18,00 % |
SIAscopy
35,6
%
| 0 | 51,3 % | 0 | 35,6 % | -37,92 % |
Ventas por región
CAD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Canada
66,0
%
| 0 | 38,0 % | 0 | 66,0 % | +55,14 % |
Europe
19,0
%
| 0 | 42,0 % | 0 | 19,0 % | -59,59 % |
United States
9,0
%
| 0 | 14,0 % | 0 | 9,0 % | -42,58 % |
Rest of World
6,0
%
| 0 | 6,0 % | 0 | 6,0 % | -10,68 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Stephen Lockyer
CEO | Chief Executive Officer | - | 25/04/23 |
Director of Finance/CFO | - | 29/04/22 | |
Bill Mitoulas
IRC | Investor Relations Contact | - | - |
Jeffrey Morris
SAM | Sales & Marketing | - | 01/11 |
Tarek El Hoss
SAM | Sales & Marketing | - | 02/08/22 |
Chantal Ward
PRN | Corporate Officer/Principal | - | - |
Mike Druhan
PRN | Corporate Officer/Principal | - | 09/09/20 |
Paul Karam
PRN | Corporate Officer/Principal | - | - |
Larry Petersen
PRN | Corporate Officer/Principal | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
David Hennigar
BRD | Director/Board Member | 84 | 19/11/01 |
Kenneth McKay
CHM | Chairman | - | 19/11/01 |
Stephen Lockyer
CEO | Chief Executive Officer | - | 25/04/23 |
Ed Ho
BRD | Director/Board Member | - | 25/04/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 269 456 602 | 252 675 606 ( 93,77 %) | 0 | 93,77 % |
Información de la empresa
Sector
Ventas por actividad
Ventas por región
Varia. 1 de ene. | Capi. | |
---|---|---|
+4,57 % | 212 mil M | |
+8,61 % | 186 mil M | |
+26,34 % | 151 mil M | |
+33,90 % | 114 mil M | |
+2,17 % | 65,57 mil M | |
+14,50 % | 52,61 mil M | |
-3,30 % | 46,8 mil M | |
-3,98 % | 38,95 mil M | |
+6,66 % | 37,64 mil M |